MELT PHARMACEUTICALS

Serial Number 97614559
732

Registration Progress

Application Filed
Sep 30, 2022
Under Examination
Sep 12, 2023
Approved for Publication
Jul 18, 2023
Published for Opposition
Jul 18, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Sep 12, 2025 45 days

Trademark Image

MELT PHARMACEUTICALS

Basic Information

Serial Number
97614559
Filing Date
September 30, 2022
Published for Opposition
July 18, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Mar 19, 2025
Application
Pending
Classes
005

Rights Holder

Melt Pharmaceuticals, Inc.

03
Address
102 Woodmont Blvd., Suite 610
Nashville, TN 37205

Ownership History

Melt Pharmaceuticals, Inc.

Original Applicant
03
Nashville, TN

Melt Pharmaceuticals, Inc.

Owner at Publication
03
Nashville, TN

Legal Representation

Attorney
Laila S. Wolfgram

USPTO Deadlines

Next Deadline
45 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
September 12, 2025
Extension Available
Until September 12, 2024

Application History

32 events
Date Code Type Description Documents
Mar 19, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 19, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 10, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 20, 2024 NOAC E CORRECTED NOA E-MAILED Loading...
Nov 20, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 20, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Nov 20, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 12, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 11, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Sep 11, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 11, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 11, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Feb 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 12, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 12, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 12, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 18, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 18, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 28, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 14, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 13, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 12, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 12, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 26, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 26, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 26, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 25, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 12, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Oct 4, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 4, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical compositions for administration prior to, during, or after a surgical procedure for conscious sedation

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"